• Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us
Federal Character
No Result
View All Result
Federal Character
  • Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us
No Result
View All Result
Federal Character
No Result
View All Result
Home Government
US Regulators Approve Low-Cost HIV Prevention Injection For Poorer Nations

US Regulators Approve Low-Cost HIV Prevention Injection For Poorer Nations

Ayobami OwolabibyAyobami Owolabi
5 days ago
in Government
Reading Time: 2 mins read
A A
0
Facebook ShareWhatsapp ShareX Share

The United States Food and Drug Administration has granted approval to a generic version of lenacapavir, a twice-yearly injection used to prevent HIV infection, paving the way for more affordable access in 120 low- and middle-income countries.

The announcement was made on Monday by the drug manufacturer and organisations involved in accelerating the development of the medication.

The generic injection is expected to cost about $40 per person annually in the countries covered by the arrangement, matching the price of existing daily HIV prevention pills.

However, health advocates say the injection could improve prevention efforts because recipients only need two doses a year, unlike the pills that must be taken every day.

US Regulators Approve Low-Cost HIV Prevention Injection For Poorer Nations

 

Lenacapavir nearly eliminated new HIV infections in two major clinical studies involving people at high risk of contracting the virus.

Carmen Pérez Casas, HIV lead at global health agency Unitaid, said the injection offered greater hope because some people struggle to maintain a daily medication routine.

“People don’t always take their daily dose of medication, ‘and if you do not take it, you cannot get protected against HIV,’” she said. “With lenacapavir, we are much more hopeful.”

Advocates believe wider access to the medication could help reduce HIV infections, AIDS-related illnesses and deaths. The World Health Organization estimates that 41 million people were living with HIV globally last year, while 570,000 died from related causes.

Carolyn Amole, who leads the HIV programme at the Clinton Health Access Initiative, said the availability of an affordable generic version could expand access to pre-exposure prophylaxis, commonly known as PrEP.

PrEP is medication taken by people who are at risk of contracting HIV to reduce their chances of infection before exposure to the virus.

“With an affordable, high-quality generic medication now available, ‘we could help to scale this to the 20 million people around the world who need PrEP,’” Amole said.

“And if we scale to those levels,” she added, “we can actually begin to bring an end to the HIV epidemic.”

The generic version will not be available for sale in the United States because Gilead Sciences, the maker of the branded version known as Yeztugo, still holds patent protection for the drug. The FDA approved Yeztugo last year.

The branded injection has a US list price of $28,218 annually before insurance coverage. Gilead officials have maintained that the cost is comparable to that of some other PrEP options.

The latest approval was granted under an established FDA programme intended to ensure the quality of HIV-related medicines supplied to other countries with support from the US government.

Although the approval is classified as “tentative” because the original product remains under patent, the designation can help accelerate regulatory clearance in other countries.

Gilead had previously been the only supplier of lenacapavir, but demand in low- and middle-income countries has exceeded available supplies.

To increase production, the company has entered into royalty-free licensing agreements with six generic drug manufacturers. The agreements cover selected countries across sub-Saharan Africa, Asia and Latin America.

Tags: federal characterForeign NewsHIV PreventioninjectionNewsPoorer NationsRegulatorsUS
Share234SendTweet147
Ayobami Owolabi

Ayobami Owolabi

Owolabi Ayobami is an emerging entertainment journalist, dedicated to delivering the latest scoop on Nollywood, music, and celebrity culture. With a keen eye for detail and a passion for storytelling, he brings fresh insights and perspectives to the entertainment beat.

Related Stories

US Expands Iran Blockade, Targets Weapons Supply Through Land Borders

US Expands Iran Blockade, Targets Weapons Supply Through Land Borders

byAyobami Owolabi
0

The United States military has announced the creation of a new task force aimed at disrupting Iran’s efforts to move advanced weapons, restricted materials and other sanctioned goods...

Ivanka Trump's Morocco Birthday Trip Cost Taxpayers $93,000 in Hotels

Ivanka Trump’s Morocco Birthday Trip Cost Taxpayers $93,000 in Hotels

bySomto Nwanolue
0

Ivanka Trump wanted a birthday party in Marrakech. The American taxpayer picked up the hotel bill. The US government spent $93,000 on five-star accommodation for Secret Service agents...

Georgia Gov. Bottoms Picks Accused Predator Tyler Perry for Transition

Georgia Gov. Bottoms Picks Accused Predator Tyler Perry for Transition

bySomto Nwanolue
0

Keisha Lance Bottoms made history as Georgia's first Black woman governor. Then she used her first days in power to protect an accused predator. Bottoms has named Tyler...

Trump Cancels Red-State Rallies Days Before Midterms in Strategy Shift

Trump To Appear On ‘60 Minutes’ For First Major Interview Since Midterm Losses

byAyobami Owolabi
0

US President Donald Trump is set to feature on Sunday’s edition of CBS’s flagship news programme, 60 Minutes, in his first extensive television interview since the Republican Party...

Next Post
US Postal Worker Charged Over Withholding 1,000 Political Campaign Mail Pieces

US Postal Worker Charged Over Withholding 1,000 Political Campaign Mail Pieces

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Federal Character

We bring to you precise and factual news.
Towson, Baltimore, Maryland, USA

Recent Posts

  • Nigeria’s Flamingos did more than beat Japan to make history at the U-17 Women’s World Cup
  • Meet The Woman Behind Fight To Stop Maryland’s $5bn Data Centre
  • US Expands Iran Blockade, Targets Weapons Supply Through Land Borders

Categories

  • Beauty
  • Business & Finance
  • Entertainment
  • Fashion & Lifestyle
  • Food & Nutrition
  • Government
  • Health
  • News
  • Politics
  • Sports
  • Tech

Weekly Newsletter

  • Home
  • About Federal Character
  • Advertise With Us
  • Cookie Policy
  • Sitemap

Copyright © FederalCharacter.com 2026 .

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
  • Government
  • Business & Finance
  • Entertainment
  • Sports
  • Tech
  • Health
  • About Federal Character
  • Advertise With Us

Copyright © FederalCharacter.com 2026 .